CryoPort (NASDAQ:CYRX) CFO Robert Stefanovich Sells 38,700 Shares of Stock

CryoPort, Inc. (NASDAQ:CYRX) CFO Robert Stefanovich sold 38,700 shares of the firm’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $7.76, for a total value of $300,312.00. Following the completion of the sale, the chief financial officer owned 255,701 shares in the company, valued at $1,984,239.76. The trade was a 13.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Robert Stefanovich also recently made the following trade(s):

• On Monday, March 16th, Robert Stefanovich sold 2,743 shares of CryoPort stock. The stock was sold at an average price of $8.00, for a total transaction of $21,944.00.

CryoPort Stock Up 2.3%

CYRX stock opened at $8.00 on Tuesday. CryoPort, Inc. has a fifty-two week low of $4.63 and a fifty-two week high of $11.45. The firm’s 50-day simple moving average is $9.23 and its 200 day simple moving average is $9.36. The stock has a market cap of $398.88 million, a PE ratio of 6.06 and a beta of 1.69.

CryoPort (NASDAQ:CYRX) last posted its earnings results on Tuesday, March 3rd. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.02). CryoPort had a net margin of 42.35% and a negative return on equity of 8.22%. The firm had revenue of $45.45 million for the quarter, compared to analyst estimates of $42.92 million. Equities analysts forecast that CryoPort, Inc. will post -0.99 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CYRX. LPL Financial LLC increased its stake in shares of CryoPort by 6.6% during the fourth quarter. LPL Financial LLC now owns 23,306 shares of the company’s stock valued at $224,000 after acquiring an additional 1,433 shares during the period. The Manufacturers Life Insurance Company lifted its position in CryoPort by 9.4% in the second quarter. The Manufacturers Life Insurance Company now owns 18,178 shares of the company’s stock worth $136,000 after purchasing an additional 1,557 shares during the period. State of Wyoming boosted its stake in CryoPort by 30.2% during the 2nd quarter. State of Wyoming now owns 14,218 shares of the company’s stock valued at $106,000 after purchasing an additional 3,301 shares in the last quarter. Intech Investment Management LLC boosted its stake in CryoPort by 14.6% during the 2nd quarter. Intech Investment Management LLC now owns 25,951 shares of the company’s stock valued at $194,000 after purchasing an additional 3,305 shares in the last quarter. Finally, Basepoint Wealth LLC acquired a new position in shares of CryoPort during the 4th quarter valued at $34,000. 92.90% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on CYRX. Weiss Ratings reissued a “sell (d+)” rating on shares of CryoPort in a report on Monday, December 29th. Wall Street Zen downgraded CryoPort from a “hold” rating to a “sell” rating in a research note on Saturday, March 7th. Finally, Needham & Company LLC boosted their price target on CryoPort from $12.00 to $13.00 and gave the stock a “buy” rating in a research report on Wednesday, March 4th. Eight investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $12.94.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.